While I don't purport to know what the FDA will do, think, or what its attitude will be with a new Board and CEO, I don't think it can get any worse. I have heard nothing to support the idea that Clinical Trials will be held up by the new Board, but perhaps you have nonpublic information to the contrary. If so, please share it, thanks.
News 
Market Data 
Discover 
AI
